Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection

被引:40
作者
Wang, B
Dyer, WB
Zaunders, JJ
Mikhail, M
Sullivan, JS
Williams, L
Haddad, DN
Harris, G
Holt, JAG
Cooper, DA
Miranda-Saksena, M
Boadle, R
Kelleher, AD
Saksena, NK
机构
[1] Univ Sydney, Westmead Hosp,Ctr Virus Res, Retroviral Genet Lab, Westmead Millennium Inst, Sydney, NSW 2145, Australia
[2] Australian Red Cross Blood Serv, Tissue Typing Dept, Viral Immunol Lab, Sydney, NSW 2000, Australia
[3] St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia
[4] Univ New S Wales, Sch Pathol, Kensington, NSW 2052, Australia
[5] Univ New S Wales, NCHECR, Darlinghurst, NSW 2010, Australia
[6] Alphega Med Ctr, Frenchs Forest, NSW 2086, Australia
[7] Microwave Therapy Ctr, Perth, WA 6005, Australia
基金
英国医学研究理事会;
关键词
HIV-1; long-term nonprogressor; helper T cells; IFN-gamma; CD8 antiviral factor; T cell activation and effector function; T cell memory;
D O I
10.1006/viro.2002.1706
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently demonstrated that a unique HIV-1-infected nonprogressor was infected with a nonevolving replication-incompetent HIV-1 strain, showing a total absence of viral evolution in vivo. Potent immune responses against HIV-1 were observed in his PBMC, despite an apparent lack of viral replication for at least 8 years. His PBMC resisted superinfection with CCR5, CXCR4, and dual-tropic HIV-1 strains, although highly purified CD4+ T cells supported infection, but without any visible cytopathic effect. Potent noncytolytic CD8+ T cell antiviral activity was shown to protect his PBMC from productive infection. This activity was not mediated by several known chemokines or IFN-gamma, which were produced at high levels after PHA activation of his CD8+ T cells, indicating the action of other CAF-like CD8 factors. This antiviral activity was a memory response, induced by HIV-specific stimulation to similar levels observed by PHA stimulation, but absent in ex vivo resting T cells. Immunological mechanisms associated with this antiviral suppressive activity included vigorous Gag-specific helper T cell proliferative responses and high-level IFN-gamma release by both CD4 and CD8 T cells. These responses were broadly directed against multiple Gag epitopes, both previously reported and some novel epitopes. Strong HIV-specific helper T cell function was also associated with strong neutralizing antibodies. Understanding how to induce these protective immune responses in other individuals could provide a major step forward in the design of effective immunotherapies or vaccines against HIV infection. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:246 / 264
页数:19
相关论文
共 81 条
[1]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[2]   CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor [J].
Barker, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S485-S488
[3]   Persistent antibody responses but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA expression [J].
Binley, JM ;
Jin, X ;
Huang, YX ;
Zhang, LQ ;
Cao, YZ ;
Ho, DD ;
Moore, JP .
JOURNAL OF VIROLOGY, 1998, 72 (04) :3472-3474
[4]   Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection [J].
Brander, C ;
Hartman, KE ;
Trocha, AK ;
Jones, NG ;
Johnson, RP ;
Korber, B ;
Wentworth, P ;
Buchbinder, SP ;
Wolinsky, S ;
Walker, BD ;
Kalams, SA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2559-2566
[5]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[6]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[7]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[8]   CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors [J].
Clegg, AO ;
Ashton, LJ ;
Biti, RA ;
Badhwar, P ;
Williamson, P ;
Kaldor, JM ;
Stewart, GJ .
AIDS, 2000, 14 (02) :103-108
[9]   CELLULAR-IMMUNITY AND A TYPE-1 CYTOKINE PROFILE IN PROTECTION AGAINST HIV-INFECTION AND PROGRESSION TO AIDS [J].
CLERICI, M ;
SHEARER, GM .
RESEARCH IN IMMUNOLOGY, 1994, 145 (8-9) :635-643
[10]   Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors [J].
Cohen, OJ ;
Vaccarezza, N ;
Lam, GK ;
Baird, BF ;
Wildt, K ;
Murphy, PM ;
Zimmerman, PA ;
Nutman, TB ;
Fox, CH ;
Hoover, S ;
Adelsberger, J ;
Baseler, M ;
Arthos, J ;
Davey, RT ;
Dewar, RL ;
Metcalf, J ;
Schwartzentruber, DJ ;
Orenstein, JM ;
Buchbinder, S ;
Saah, AJ ;
Detels, R ;
Phair, J ;
Rinaldo, C ;
Margolick, JB ;
Pantaleo, G ;
Fauci, AS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1581-1589